Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours Β· Estimated delivery Aug 26 - Aug 31
All findings referenced are from peer-reviewed preclinical studies
In rodent tendon transection models, BPC-157 administered at doses in the range of 10 mcg/kg intraperitoneally produced measurable improvements in tendon-to-bone repair markers within two weeks compared to vehicle controls
Enhanced cellular polysulfides negatively regulate TLR4 signaling and mitigate lethal endotoxin shock
No human clinical trials for this route exist
The BPC-157 TB-500 10mg peptide blend is a combined research peptide vial containing 5mg BPC-157 and 5mg TB-500 (Thymosin Beta-4 fragment) in lyophilised form
US$ 28.97
US$ 21.45
US$ 27.44
US$ 22.03
US$ 23.36
